CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients

Published:2016-03-31 Issue:1 Volume:16 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Simonsson Maria,Veerla Srinivas,Markkula Andrea,Rose Carsten,Ingvar Christian,Jernström Helena

Funder

Cancerfonden

Vetenskapsrådet

Region Skane ALF (SE)

VINNOVA

Medicinska Fakulteten, LU (SE)

Fru Berta Kamprads Stiftelse

Gunnar Nilssons Cancerstiftelse

Swedish Breast Cancer Group (BRO) (SE)

SUS Hospital Fund (SE)

Märta Winklers Stiftelse

Gustav V Jubileumsfond (SE)

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-016-2284-3

Reference57 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

2. Fernö M, Borg Å, Johansson U, Norgren A, Olsson H, Ryden S, Sellberg G. Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group. Acta Oncol. 1990;29(2):129–35.

3. Hou N, Huo D. A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase. Breast Cancer Res Treat. 2013;138(2):633–41.

4. Miller WR, Larionov AA. Understanding the mechanisms of aromatase inhibitor resistance. Breast Cancer Res. 2012;14(1):201.

5. Jernström H, Bågeman E, Rose C, Jönsson PE, Ingvar C. CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients. Br J Cancer. 2009;101(11):1817–23.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the molecular significance of CYP1A2 (rs762551; c.-9–154 C>A) genetic variant on breast carcinoma susceptibility: Insights from case-control study and meta-analysis;Pathology - Research and Practice;2024-09

2. Research Progress on Aromatase Inhibitors Causing Arthralgia in Early Breast Cancer;Advances in Clinical Medicine;2022

3. The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study;Frontiers in Oncology;2021-05-20

4. Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies;Biomedicines;2021-03-12

5. Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors;The Breast;2020-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3